Cynosure Group LLC Has $297,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

04 Apr 2025, 12:08 by Jessica Moore · The Cerbat Gem

Cynosure Group LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 34.6% during the 4th quarter, HoldingsChannel reports. The firm owned 587 shares of the healthcare conglomerate’s stock after selling 310 shares during the quarter. Cynosure Group LLC’s holdings in UnitedHealth Group were worth $297,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter worth $32,000. Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $40,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth about $57,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $540.87 on Friday. The firm’s 50 day simple moving average is $509.39 and its 200 day simple moving average is $542.82. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $494.74 billion, a price-to-earnings ratio of 34.89, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on UNH shares. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $629.32.

Read Our Latest Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.